How Value Analysis Committees’ Lines of Questioning Can Directly Affect Value Equation Outputs

By AHRMM

John Kelty from W.L. Gore & Associates discusses how value analysis committees can determine a medical devices value when evaluating new products. 

Related Resources

White Papers
AHRMM19 CQO Summit White Paper | CQO: The Power of Clinical Integration
AHRMM19 CQO Summit White Paper entitled CQO: The Power of Clinical Integration.
On-Demand Educational Webinars
A Question of Ownership Aligning Processes Between Accounts Payable and Supply Chain
In many organizations, the relationship between supply chain and accounts payable is strained due to lack of clarity and ownership. This webinar…
On-Demand Educational Webinars
Value Analysis Best Practices: A Panel Discussion
A panel of three leading experts in the value analysis field candidly share information regarding the state of value analysis when they entered the…
Podcasts
Value Analysis 201: Organizing Data to Analyze Product and Equipment Clinical Outcomes
A value analysis process to verify the achievement of the outcomes desired will result in making decisions based on the data, celebrating achieveme
On-Demand Educational Webinars
Reduce Costs with Rep-less Model Strategic Purchasing
Uncontrolled variation is the enemy of quality, and quite a bit of uncontrolled variation exists in the medical device industry today. Using dis-…
e-Learning
WHY, WHAT, and HOW of Strategic Planning